L&C Bio Co., Ltd (290650.KQ)

KRW 20700.0

(0.49%)

Revenue Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual revenue in 2023 was 68.86 Billion KRW , up 31.0% from previous year.
L&C Bio Co., Ltd's latest quarterly revenue in 2024 Q2 was 17.89 Billion KRW , up 8.07% from previous quarter.
L&C Bio Co., Ltd reported a annual revenue of 52.57 Billion KRW in annual revenue 2022, up 15.1% from previous year.
L&C Bio Co., Ltd reported a annual revenue of 45.67 Billion KRW in annual revenue 2021, up 38.53% from previous year.
L&C Bio Co., Ltd reported a quarterly revenue of 17.89 Billion KRW for 2024 Q2, up 8.07% from previous quarter.
L&C Bio Co., Ltd reported a quarterly revenue of 14.79 Billion KRW for 2023 Q1, down -5.41% from previous quarter.

Annual Revenue Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Revenue of L&C Bio Co., Ltd (2023 - 2015)

Year	Revenue	Revenue Growth
2023	68.86 Billion KRW	31.0%
2022	52.57 Billion KRW	15.1%
2021	45.67 Billion KRW	38.53%
2020	32.97 Billion KRW	13.11%
2019	29.15 Billion KRW	37.24%
2018	21.24 Billion KRW	18.66%
2017	17.9 Billion KRW	51.42%
2016	11.82 Billion KRW	31.37%
2015	8.99 Billion KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q1	16.56 Billion KRW	-2.72%
2024 Q2	17.89 Billion KRW	8.07%
2023 Q1	14.79 Billion KRW	-5.41%
2023 Q4	17.02 Billion KRW	-17.19%
2023 FY	68.86 Billion KRW	31.0%
2023 Q2	16.48 Billion KRW	11.44%
2023 Q3	20.55 Billion KRW	24.67%
2022 Q2	13.14 Billion KRW	19.5%
2022 FY	52.57 Billion KRW	15.1%
2022 Q4	15.64 Billion KRW	22.33%
2022 Q3	12.78 Billion KRW	-2.71%
2022 Q1	10.99 Billion KRW	-18.34%
2021 Q2	10.69 Billion KRW	11.67%
2021 Q3	11.94 Billion KRW	11.69%
2021 Q4	13.46 Billion KRW	12.79%
2021 FY	45.67 Billion KRW	38.53%
2021 Q1	9.57 Billion KRW	2.18%
2020 Q3	8.31 Billion KRW	5.61%
2020 Q4	9.37 Billion KRW	12.64%
2020 FY	32.97 Billion KRW	13.11%
2020 Q1	7.4 Billion KRW	-10.39%
2020 Q2	7.87 Billion KRW	6.35%
2019 Q4	8.26 Billion KRW	20.47%
2019 FY	29.15 Billion KRW	37.24%
2019 Q3	6.86 Billion KRW	-12.04%
2019 Q2	7.8 Billion KRW	25.31%
2019 Q1	6.22 Billion KRW	-3.67%
2018 Q2	5.44 Billion KRW	12.47%
2018 Q1	4.84 Billion KRW	0.0%
2018 Q3	4.49 Billion KRW	-17.54%
2018 Q4	6.46 Billion KRW	43.89%
2018 FY	21.24 Billion KRW	18.66%
2017 FY	17.9 Billion KRW	51.42%
2016 FY	11.82 Billion KRW	31.37%
2015 FY	8.99 Billion KRW	0.0%

Peer Revenue Comparison of L&C Bio Co., Ltd

Name	Revenue	Revenue Difference
Osang Healthcare Co.,Ltd	355.84 Billion KRW	80.646%
InBody Co.,Ltd	170.35 Billion KRW	59.572%
Curexo Inc.	72.88 Billion KRW	5.506%
Seegene, Inc.	367.37 Billion KRW	81.254%
i-SENS, Inc.	265.12 Billion KRW	74.023%
Ray Co., Ltd.	145.88 Billion KRW	52.791%
Gencurix Inc.	2.6 Billion KRW	-2548.505%
Sugentech Inc.	7.13 Billion KRW	-865.6%